Genomize
PrivateMomentum
Top 5%
of companies Caplight tracks
Company Overview
Genomize is a healthtech company that provides a bioinformatics platform designed for genomic data analysis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Healthcare Analytics, Precision Medicine, Medical AI, Platform-as-a-Service
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genomize Comparables
Compare Genomize with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Geneyx | 91% | |
| Euformatics | 87% | |
| SeqOne | 83% | |
Genomize Funding Rounds
Historical fundraising activity
Genomize Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ScaleX Ventures | Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 6, 4.5x the trailing average.
- Jan 26, 2026
Monthly visitors increased 184% MoM, reaching 3.3K.
Genomize Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Genomize's valuation, stock price, and market status.